Resources from the same session
396O - Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study
Presenter: Thierry André
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
397O - Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study
Presenter: Erika Martinelli
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
398O - Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial
Presenter: Come Lepage
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
399O - Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trial
Presenter: Sara Lonardi
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
Q&A and live discussion
Presenter: Michel Ducreux
Session: Proffered Paper - GI, colorectal
Resources:
Webcast
Invited Discussant 398O and 399O
Presenter: Timothy Price
Session: Proffered Paper - GI, colorectal
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Michel Ducreux
Session: Proffered Paper - GI, colorectal
Resources:
Webcast